Resources  /  Conditions

Visceral fat vs subcutaneous fat

Two people at the same weight can carry very different amounts of each. It is the clearest reason BMI is a poor instrument for one person.

Educational — not a recommendation to take anything

Where it sits matters more than how much there is

Fat under the skin and fat around the organs behave like two different tissues. Subcutaneous fat is the layer you can pinch — hips, thighs, the back of the arms. Visceral fat sits inside the abdominal cavity, packed between and around the liver, pancreas and intestines, and you cannot pinch it at all.

Two people at the same weight and the same BMI can carry very different amounts of each, and their metabolic risk differs accordingly. This is the single clearest reason BMI is a poor instrument for an individual.

Why visceral fat behaves differently

Three things set it apart, and they compound.

  • It drains into the liver. Visceral fat releases fatty acids directly into the portal vein, which goes straight to the liver rather than into general circulation. The liver therefore sees a far higher concentration than the rest of the body does.
  • It is more metabolically active, releasing inflammatory signalling molecules at a higher rate than subcutaneous fat.
  • It is more readily mobilised, which is the one piece of good news: it tends to respond earlier than subcutaneous fat when weight comes down.

Subcutaneous fat on the hips and thighs, by contrast, is associated in several studies with lower metabolic risk at a given total weight. It appears to act partly as a safe storage depot — somewhere for surplus energy to go that is not the liver.

The spillover idea

The most useful way to think about this is capacity. Everyone has a limit to how much fat they can safely store under the skin, and that limit is largely inherited.

Once it is reached, surplus energy goes elsewhere — into the viscera, and into organs that were not designed to store it: the liver, the pancreas, the muscle. That is ectopic fat, and it tracks with insulin resistance more closely than total body fat does.

It also explains a pattern that otherwise looks like a contradiction: people of normal weight with a metabolic profile that looks much worse than their size suggests. Their storage capacity is simply smaller, and it has been exceeded sooner. South Asian populations show this at lower BMIs than European ones, which is why some guidelines use lower thresholds for them.

How it is measured, from best to most practical

  • MRI or CT — the reference methods. They quantify it directly, and no clinic uses them for this routinely.
  • DEXA — estimates a visceral fat area as part of a body composition scan. Available privately here, at a cost.
  • Waist circumference — crude, free, and the one most strongly validated against outcomes. Measured at the midpoint between the lowest rib and the top of the hip bone, at the end of a normal breath out.
  • Waist‑to‑height ratio — a single rule of thumb that has held up well: keep your waist under half your height. It needs no tables and no correction for sex.

It is worth noticing that the cheapest method here is also among the better predictors. A tape measure costs nothing and a body composition scan costs real money, and the scan's advantage is smaller than its price suggests.

What shifts it

Visceral fat responds to the ordinary things, and it tends to respond first — which is why metabolic markers can improve substantially before the scales move much.

There is no way to target it. Abdominal exercise does not reduce abdominal fat; that idea has been tested and does not hold. What is associated with visceral fat specifically is overall energy balance, regular activity of almost any kind, sleep, and alcohol intake.

Why this is on a clinic's website

Because it reframes what progress looks like. If someone's waist has come down four centimetres, their triglycerides have fallen and their ALT has normalised while the scale has barely moved, that is a good outcome being measured by the wrong instrument.

A clinic that reports only weight will miss it, and a patient who watches only weight will be discouraged by it.

The boundary

Nothing here says what your own distribution is or what should be done about it. A tape measure and a panel are a start; what they mean together is a conversation with a physician.

Measure it rather than guess

Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.

Measure my biomarkers